Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2013 Nov 13;14(5):591-9.
doi: 10.1016/j.chom.2013.10.007.

Human cytomegalovirus tegument protein pUL83 inhibits IFI16-mediated DNA sensing for immune evasion

Tuo Li  1 , Jin Chen, Ileana M Cristea
Affiliations

Human cytomegalovirus tegument protein pUL83 inhibits IFI16-mediated DNA sensing for immune evasion

Tuo Li et al. Cell Host Microbe. .

Abstract

Nuclear sensing of viral DNA has emerged as an essential step in innate immune responses against herpesviruses. Here, we provide mechanistic insight into host recognition of human cytomegalovirus (HCMV) and subsequent immune evasion by this prominent DNA virus. We establish that the interferon-inducible protein IFI16 acts as a nuclear DNA sensor following HCMV infection, binding viral DNA and triggering expression of antiviral cytokines via the STING-TBK1-IRF3 signaling pathway. The HCMV tegument protein pUL83 inhibits this response by interacting with the IFI16 pyrin domain, blocking its oligomerization upon DNA sensing and subsequent immune signals. pUL83 disrupts IFI16 by concerted action of its N- and C-terminal domains, in which an evolutionarily conserved N-terminal pyrin association domain (PAD) binds IFI16. Additionally, phosphorylation of the N-terminal domain modulates pUL83-mediated inhibition of pyrin aggregation. Collectively, our data elucidate the interplay between host DNA sensing and HCMV immune evasion, providing targets for restoring antiviral immunity.

PubMed Disclaimer

Figures

Figure 1
Figure 1. pUL83 antagonizes IFI16-mediated antiviral response
(A) mRNA levels of cytokines in HFFs infected with WT or ΔUL83 HCMV or mock-infected, at 3 or 6 hpi (moi = 5). Data shown as mean +/− SEM, n = 3. (B) Protein levels of IRF-1, IRF-3, NF-κB p65, and other markers were measured by Western blot in total cell lysates and nuclear fractions of HFFs infected as in (A). (C) mRNA levels of cytokines in HFFs infected with UV-treated WT or ΔUL83 HCMV, at 6 hpi (moi = 5). Western blots show IE-1, pUL83 and loading control (actin) protein levels. (D) HFFs stably expressing pUL83-Flag or control were infected with mock or ΔUL83 strain. Western blots show protein levels for pUL83 and IFI16. IF images show nuclear localization of pUL83-Flag. mRNA levels of cytokines measured by qPCR as in (A). (E) Endogenous IFI16, STING, TBK-1, IRF-3 and MAVS were stably knocked down in HFFs by shRNA. mRNA levels of cytokines in response to mock or ΔUL83 strain were measured as in (A). (F) Protein levels for IRF-1, NF-κB p65, and other markers in nuclear fraction or total lysates were measured by Western blot. See also Figure S1.
Figure 2
Figure 2. pUL83 blocks nuclear pyrin aggregation
(A) ChIP assays test the association of endogenous IFI16 with HCMV DNA and host DNA in infected HFFs. (B) Constructs of pUL83, IFI16 and other PYHIN proteins. (C) Co-IP assays of pUL83-Flag interaction with IFI16 constructs. (D) Co-IP assays of pUL83 interaction with pyrin domains of PYHIN proteins. (E) 293T cells were transfected with plasmids (1:5) of Pyrin-GFP and mCherry or pUL83-mCherry. Direct fluorescent images illustrate PY-GFPs. (F) As in (E), cells from random microscopy fields were analyzed for PY-GFP distributions. Bars: percentages of diffuse (yellow) or aggregation (blue) patterns as mean +/− SEM. (G) As in (E), bars show IFI16-PY-GFP distributions as a function of the pUL83-mCherry/mCherry ratio. (H) HEK293T cells transiently transfected with GFP alone or GFP fusions with full-length (FL), PY or HIN domains of IFI16, in the presence or absence of exogenous pUL83. Cell lysates were cross-linked and the oligomerization status was assessed by Western blotting with an anti-GFP antibody. (I) Western blot shows migration of endogenous IFI16 in infected HFFs cross-linked with glutaraldehyde. Protein levels in total lysates prior to crosslinking are shown. See also Figure S2, Movie S1.
Figure 3
Figure 3. Interference of pyrin aggregation requires both the Pyrin Association Domain (PAD) and the C-terminal domain of pUL83
(A) Schematic of pUL83 shows its bipartite structure, conservation scores, predicted disorder degrees, and phosphorylation sites. (B) Schematics of pUL83 constructs; those lacking NLS (red) were supplemented with SV40-NLS (orange) to ensure nuclear localization. (C) Interactions of pUL83-Flag constructs in (B) (preys) with IFI16-PY-GFP (bait) were tested by co-IP. (D) PAD-mCherry and pUL83-mCherry were tested for PY-interference as in Figure 2F; diffuse (yellow) or aggregation (blue) patterns shown as mean +/− SEM. (E) IF shows the ability of pUL83 constructs in (B) to interfere with IFI16-PY-GFP aggregation. (F) Two models for the role of the pUL83 linker in PY interference. (G) Mutants of PAD phosphosites were tested for pyrin-interference as in (D). Statistics: ns, not significant; *, p< 0.05; **, p< 0.01. Western blots show levels of pUL83 constructs. (H) Predicted structure models for pUL83 (rainbow) and IFI16 Pyrin (green). Docking shows arbitrary size fitting. (I) SDS-PAGE of recombinant complex of GST-PAD and sumo-IFI16-Pyrin. See also Figure S3
Figure 4
Figure 4. Working model for IFI16-mediated nuclear DNA sensing and pUL83-mediated immune evasion
IFI16 detects nuclear HCMV DNA via HIN domains, oligomerizes via the pyrin domain, and activates STING-mediated cytokine expression. pUL83 blocks IFI16 pyrin aggregation and hijacks IFI16 to help activate HCMV MIEP. pUL83 is partly inhibited by phosphorylation at S364. The balance between the DNA sensing and immune evasion determines the immunological outcome of HCMV infections.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Abate DA, Watanabe S, Mocarski ES. Major human cytomegalovirus structural protein pp65 (ppUL83) prevents interferon response factor 3 activation in the interferon response. Journal of virology. 2004;78:10995–11006. - PMC - PubMed
    1. Ansari MA, Singh VV, Dutta S, Veettil MV, Dutta D, Chikoti L, Lu J, Everly D, Chandran B. Constitutive Interferon-Inducible Protein 16-Inflammasome Activation during Epstein-Barr Virus Latency I, II, and III in B and Epithelial Cells. Journal of virology. 2013;87:8606–8623. - PMC - PubMed
    1. Arnon TI, Achdout H, Levi O, Markel G, Saleh N, Katz G, Gazit R, Gonen-Gross T, Hanna J, Nahari E, et al. Inhibition of the NKp30 activating receptor by pp65 of human cytomegalovirus. Nat Immunol. 2005;6:515–523. - PubMed
    1. Browne EP, Shenk T. Human cytomegalovirus UL83-coded pp65 virion protein inhibits antiviral gene expression in infected cells. Proceedings of the National Academy of Sciences of the United States of America. 2003;100:11439–11444. - PMC - PubMed
    1. Cheeran MC, Lokensgard JR, Schleiss MR. Neuropathogenesis of congenital cytomegalovirus infection: disease mechanisms and prospects for intervention. Clin Microbiol Rev. 2009;22:99–126. Table of Contents. - PMC - PubMed

Publication types

MeSH terms